iomeprol has been researched along with Kidney Failure in 4 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Swanberg, J | 1 |
| Nyman, R | 1 |
| Magnusson, A | 1 |
| Wanhainen, A | 1 |
| Cordaro, M | 1 |
| Impellizzeri, D | 1 |
| Bruschetta, G | 1 |
| Siracusa, R | 1 |
| Crupi, R | 1 |
| Di Paola, R | 1 |
| Esposito, E | 1 |
| Cuzzocrea, S | 1 |
| Morikawa, S | 1 |
| Sone, T | 1 |
| Tsuboi, H | 1 |
| Mukawa, H | 1 |
| Morishima, I | 1 |
| Uesugi, M | 1 |
| Morita, Y | 1 |
| Numaguchi, Y | 1 |
| Okumura, K | 1 |
| Murohara, T | 1 |
| Kimmel, M | 1 |
| Butscheid, M | 1 |
| Brenner, S | 1 |
| Kuhlmann, U | 1 |
| Klotz, U | 1 |
| Alscher, DM | 1 |
2 trials available for iomeprol and Kidney Failure
| Article | Year |
|---|---|
Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Contrast Media; Coronary Angiography; Creatinine | 2009 |
Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Disease; | 2008 |
2 other studies available for iomeprol and Kidney Failure
| Article | Year |
|---|---|
Selective intra-arterial dual-energy CT angiography (s-CTA) in lower extremity arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Arterial Occlusive Diseases; | 2014 |
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy.
Topics: Acute-Phase Proteins; Amides; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Ur | 2016 |